Abstract
Central nervous system (CNS) atypical teratoid/rhabdoid tumor (AT/RT) is a rare, aggressive tumor that most often affects very young children. The common decisive molecular defect in AT/RT has been shown to be a single genetic alteration, i.e., the loss of hSNF5 gene that encodes for a subunit of the SWI/SNF complex that modulates chromatin remodeling activities. As a result, AT/RT cells display unregulated cell proliferation due to the dysfunction of an important epigenetic control. We have previously demonstrated the preclinical efficacy of the oncolytic double-deleted vaccinia virus (VVDD) against AT/RT. Here we report the establishment of a modified VVDD engineered to express wild type hSNF5 gene. We show that this reconstructed vaccinia virus retains comparable infectivity and in vitro cytotoxicity of the parent strain. However, in addition, hSNF5-arming of VVDD results in a decreased cell cycle S phase population and down-regulation of cyclin D1. These findings suggest that hSNF5-arming of VVDD may increase the efficacy in the treatment of AT/RT and validates, as a proof-of-concept, an experimental approach to enhance the effective use of novel modified oncolytic viruses in the treatment of tumors with loss of a tumor sup...Continue Reading
References
Feb 1, 1994·Pathology, Research and Practice·Y NagashimaK Misugi
Jun 26, 2002·Oncogene·Keisuke AeYoshihiro Kitamura
Jul 26, 2002·Molecular and Cellular Biology·Zhi-Kai ZhangGanjam V Kalpana
Aug 1, 2002·Oncogene·Bryan L BetzBernard E Weissman
Sep 13, 2002·Oncogene·Isabella VersteegeOlivier Delattre
Nov 8, 2003·The Journal of Biological Chemistry·Igor OruetxebarriaC Peter Verrijzer
Jan 12, 2005·The Journal of Urology·Istvan FodorMichael Lilly
Nov 17, 2005·Cancer Research·Jingjing ChaiBernard E Weissman
Nov 23, 2005·Proceedings of the National Academy of Sciences of the United States of America·Michael S IsakoffCharles W M Roberts
Jan 18, 2006·Human Gene Therapy·Arpana M NaikDavid L Bartlett
May 16, 2008·Gene Therapy·J FoloppeP Erbs
Jul 25, 2008·Journal of Neuro-oncology·Aru NarendranDouglas Strother
Nov 13, 2009·Journal of Virology·Kilian GuseAkseli Hemminki
Sep 3, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·XueQing LunPeter A Forsyth
Sep 22, 2012·Pediatric Blood & Cancer·Mark W KieranJaclyn A Biegel
Nov 21, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Christian Frezza, Carla P Martins
Jul 3, 2013·Molecular Oncology·Xueqing LunAru Narendran
Oct 9, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Herbert J ZehDavid L Bartlett
Apr 4, 2015·Science·Beatriz M CarrenoGerald P Linette
May 21, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Stephanie Downs-CannerDavid L Bartlett
Oct 4, 2016·Cancer Management and Research·Ahitagni BiswasPramod Kumar Julka
May 11, 2018·Journal of Korean Neurosurgical Society·Elizabeth Anne RichardsonAnnie Huang
Jan 27, 2019·Cancer Immunology Research·Elizabeth K DuperretDavid B Weiner
Aug 25, 2019·Molecular Cancer·Miao PengZhaoyang Zeng
Dec 25, 2019·Current Opinion in Biotechnology·Erkko Ylösmäki, Vincenzo Cerullo
Jun 3, 2020·Theranostics·Xiaotong ChenBaorui Liu